JP Patent

JP7782035B2 — Ｊａｋ２阻害剤としての６－ヘテロアリールオキシベンゾイミダゾール及びアザベンゾイミダゾール

Assigned to エイジャックスセラピューティクス，インコーポレイテッド · Expires 2025-12-08 · 0y expired

What this patent protects

Patent listed against ponatinib-hydrochloride.

Drugs covered by this patent

ponatinib-hydrochloride (PONATINIB HYDROCHLORIDE)

Patent Metadata

Patent number: JP7782035B2
Jurisdiction: JP
Classification: —
Expires: 2025-12-08
Drug substance claim: No
Drug product claim: No
Assignee: エイジャックスセラピューティクス，インコーポレイテッド
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.